Ad
Search
Generic filters
Filter by content type
Taxonomy terms

ANGO – AngioDynamics Inc

🔒

Subscribe for full access

Unlock Industry-grade Shariah Compliance for US, UK, Canada, Germany, GCC, Europe and India. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.

Get started from just $1/month

Ad

Recommendation Rating

2

1

2

3

4

5

1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL

Analysts’ Price Targets

Mean 31

Low: 27

High: 35

Total Analysts: 4

Company Profile

AngioDynamics, Inc. is a medical technology company. The Company is focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients. Its products offerings fall within three global business units (GBUs): Endovascular Therapies (VIT), Oncology/Surgery (OS) and Vascular Access (VA). Its products include Auryon, Thrombectomy, Peripheral Products (Core), BioFlo, Midlines, Peripherally Inserted Central Catheter (PICC), C3 Wave PICC tip location system, Ports, Dialysis Products, Venous Insufficiency, Microwave Ablation, Radiofrequency Ablation, BioSentry Tract Sealant System, IsoLoc Endorectal Balloon and Alatus Vaginal Balloon Packing System. Its Thrombus Management portfolio includes the AlphaVac System, AngioVac venous drainage system, Thrombolytic catheters and NanoKnife. Its Peripheral Products (Core) include Angiographic Products and Accessories, Drainage Products and Micro Access Kits.

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan

Ad

Responses